We have state-of-the-art facility, technology for COVID-19 testing at our ICMR labs to provide the accurate & timely reports. The following are the major innovation we have brought in respect to COVID-19 testing -
Various molecular tests can be used to detect RNA virus infections.
The RT-qPCR test is currently regarded as the gold-standard, but its sensitivity to residual viral RNA genome fragments can lead to false-positive results long after a patient has recovered from a viral infection.
We here modified the RT-qPCR protocol to make it less sensitive to residual viral RNA genome fragments, reducing the likelihood for false-positive results in recovered COVID-19 patients.
The method may improve test-to-release protocols, expand the tools available for clinical testing, and help reduce hospital encumbrance.
Read on:
https://www.medrxiv.org/content/10.1101/2021.11.11.21266219v1